Hsbc Holdings PLC Cuts Stock Holdings in Teleflex Incorporated $TFX

Hsbc Holdings PLC reduced its position in shares of Teleflex Incorporated (NYSE:TFX) by 98.2% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,201 shares of the medical technology company’s stock after selling 119,809 shares during the period. Hsbc Holdings PLC’s holdings in Teleflex were worth $303,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. MassMutual Private Wealth & Trust FSB raised its holdings in Teleflex by 103.1% during the first quarter. MassMutual Private Wealth & Trust FSB now owns 197 shares of the medical technology company’s stock worth $27,000 after purchasing an additional 100 shares in the last quarter. Banque Cantonale Vaudoise purchased a new position in Teleflex during the first quarter worth about $27,000. Costello Asset Management INC purchased a new position in Teleflex during the first quarter worth about $28,000. Brooklyn Investment Group raised its holdings in Teleflex by 258.6% during the first quarter. Brooklyn Investment Group now owns 208 shares of the medical technology company’s stock worth $29,000 after purchasing an additional 150 shares in the last quarter. Finally, Whipplewood Advisors LLC raised its holdings in Teleflex by 7,700.0% during the first quarter. Whipplewood Advisors LLC now owns 234 shares of the medical technology company’s stock worth $32,000 after purchasing an additional 231 shares in the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Teleflex

In other Teleflex news, Director Gretchen R. Haggerty acquired 500 shares of the company’s stock in a transaction dated Wednesday, August 6th. The stock was acquired at an average cost of $114.75 per share, with a total value of $57,375.00. Following the purchase, the director directly owned 6,305 shares in the company, valued at approximately $723,498.75. This trade represents a 8.61% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link. Also, CEO Liam Kelly bought 1,500 shares of the firm’s stock in a transaction that occurred on Tuesday, August 5th. The shares were purchased at an average price of $115.07 per share, for a total transaction of $172,605.00. Following the transaction, the chief executive officer owned 45,267 shares of the company’s stock, valued at $5,208,873.69. The trade was a 3.43% increase in their position. The disclosure for this purchase can be found here. Over the last 90 days, insiders bought 5,500 shares of company stock worth $633,590. 1.40% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of research analysts have issued reports on the stock. Wall Street Zen cut shares of Teleflex from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 30th. Mizuho increased their target price on shares of Teleflex from $130.00 to $135.00 and gave the company a “neutral” rating in a report on Friday, August 1st. Royal Bank Of Canada increased their target price on shares of Teleflex from $130.00 to $135.00 and gave the company a “sector perform” rating in a report on Friday, August 1st. Finally, Wells Fargo & Company dropped their target price on shares of Teleflex from $137.00 to $131.00 and set an “equal weight” rating for the company in a report on Friday, August 1st. One research analyst has rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $141.57.

Teleflex Trading Down 0.8%

Shares of TFX opened at $126.07 on Thursday. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.41 and a quick ratio of 1.44. The firm has a 50 day simple moving average of $119.50 and a 200-day simple moving average of $128.53. Teleflex Incorporated has a 1-year low of $108.90 and a 1-year high of $249.90. The stock has a market cap of $5.57 billion, a price-to-earnings ratio of 29.66, a price-to-earnings-growth ratio of 1.76 and a beta of 1.08.

Teleflex (NYSE:TFX) last issued its quarterly earnings data on Thursday, July 31st. The medical technology company reported $3.73 earnings per share for the quarter, topping analysts’ consensus estimates of $3.36 by $0.37. Teleflex had a net margin of 6.31% and a return on equity of 15.08%. The business had revenue of $780.90 million during the quarter, compared to analysts’ expectations of $771.53 million. During the same period last year, the company posted $3.42 EPS. The company’s revenue was up 4.2% on a year-over-year basis. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. Equities analysts forecast that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, September 15th. Stockholders of record on Friday, August 15th will be paid a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date of this dividend is Friday, August 15th. Teleflex’s dividend payout ratio (DPR) is 32.00%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.